BioCardia (BCDA) News Today $2.18 0.00 (0.00%) As of 03:59 PM Eastern Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 Time Period Positive Outlook on BioCardia: Strategic Growth and Regulatory Advancements Drive Buy RatingDecember 18, 2024 | markets.businessinsider.comBioCardia Announces Commercial Availability of Morph® DNA™ Steerable Introducer Product FamilyDecember 17, 2024 | markets.businessinsider.comBioCardia Announces Positive Consultation with Japan PMDA on CardiAMP Cell Therapy for Ischemic Heart FailureDecember 4, 2024 | globenewswire.comBioCardia Reports Q3 2024 Progress and FinancialsNovember 14, 2024 | markets.businessinsider.comBioCardia’s Strong Q3 Performance and Strategic Trials Drive Buy RatingNovember 14, 2024 | markets.businessinsider.comBioCardia, Inc. (BCDA) Q3 2024 Earnings Call TranscriptNovember 13, 2024 | seekingalpha.comBioCardia Reports Third Quarter 2024 Business Highlights and Financial ResultsNovember 13, 2024 | markets.businessinsider.comPromising Outlook for BioCardia with Advancements in CardiAMP HF Program and Personalized Treatment ApproachOctober 29, 2024 | markets.businessinsider.comBioCardia completes last protocol specified follow-up visit in CardiAMP HFOctober 29, 2024 | markets.businessinsider.comBioCardia Completes Phase III Randomized Double-Blind Controlled Trial of Autologous Cell Therapy for Ischemic Heart FailureOctober 28, 2024 | markets.businessinsider.comBioCardia Inc (BCDA) Q2 2024 Earnings Call Highlights: Strategic Advances Amid Financial ChallengesOctober 9, 2024 | finance.yahoo.comBioCardia, Inc.: BioCardia Regains Full Compliance with Nasdaq Listing RequirementsSeptember 18, 2024 | finanznachrichten.deBioCardia Regains Full Compliance with Nasdaq Listing RequirementsSeptember 18, 2024 | globenewswire.comBioCardia Announces Closing of Upsized $7.2 Million Public Offering Priced At-The-Market Under Nasdaq RulesSeptember 9, 2024 | globenewswire.comBioCardia Announces FDA Market Clearance of Morph® DNA(TM) Steerable Introducer Product FamilyAugust 31, 2024 | stockhouse.comWhat In The World Is Going On With UTime (WTO) Stock Today?August 30, 2024 | benzinga.comEnsysce Biosciences (ENSC) Stock Is Down 30% Today: What's Going On?August 30, 2024 | msn.comWhy BioCardia (BCDA) Stock Is Falling TodayAugust 30, 2024 | msn.comBioCardia Shares Drop 10% After Public Offering PricesAugust 30, 2024 | marketwatch.comBioCardia Announces Pricing of Upsized $7.2 Million Public Offering Priced At-The-Market Under Nasdaq RulesAugust 30, 2024 | tmcnet.comBioCardia, Inc.: BioCardia Announces FDA Market Clearance of Morph DNA Steerable Introducer Product FamilyAugust 29, 2024 | finanznachrichten.deWhy BioCardia (BCDA) Stock Is Up 95% TodayAugust 29, 2024 | msn.comBioCardia Announces FDA Market Clearance of Morph® DNA™ Steerable Introducer Product FamilyAugust 29, 2024 | globenewswire.comStock Market Today: Dow futures rise as Nvidia results drive rotation from megacap techAugust 29, 2024 | marketwatch.comBioCardia, Inc.: FDA Approves CardiAMP Heart Failure II Protocol Amendment to Use Proprietary Cell Population Analysis Screening to Define TreatmentAugust 21, 2024 | finanznachrichten.deFDA Approves CardiAMP® Heart Failure II Protocol Amendment to Use Proprietary Cell Population Analysis Screening to Define TreatmentAugust 21, 2024 | globenewswire.comTAL Aug 2024 13.000 callAugust 17, 2024 | ca.finance.yahoo.comTAL Aug 2024 11.000 putAugust 17, 2024 | ca.finance.yahoo.comTAL Aug 2024 8.000 putAugust 17, 2024 | ca.finance.yahoo.comMercer Global Listed Infras A12H0.2700€ (0P0001L5K4.F)August 16, 2024 | finance.yahoo.comBioCardia, Inc.: BioCardia Reports Second Quarter 2024 Business Highlights and Financial ResultsAugust 14, 2024 | finanznachrichten.deBioCardia Reports Second Quarter 2024 Business Highlights and Financial ResultsAugust 13, 2024 | globenewswire.comBioCardia Submits for FDA Approval of Morph® DNA™ Steerable Introducer Product FamilyJuly 30, 2024 | markets.businessinsider.comBuy Rating Affirmed: Promising CardiAMP HF Clinical Trials and CMS Financial Support Signal Strong ProspectsJuly 27, 2024 | markets.businessinsider.comPatient Enrollment Commenced in Pivotal Phase 3 Trial of CardiAMP Cell Therapy for the Treatment of Ischemic Heart FailureJuly 25, 2024 | stockhouse.comBioCardia Announces United States Patent Issuance on Morph DNA Multi-Directional Steerable Catheter Transseptal ApplicationJuly 17, 2024 | globenewswire.comBioCardia Announces United States Patent Issuance on Intramyocardial Delivery of Cell Aggregates to the Heart Including Minimally Invasive Radial Artery ApproachJune 7, 2024 | globenewswire.comBioCardia, Inc.: BioCardia Announces Reverse Stock SplitMay 22, 2024 | finanznachrichten.deBioCardia Announces Reverse Stock SplitMay 21, 2024 | globenewswire.comBioCardia, Inc. (BCDA)May 18, 2024 | finance.yahoo.comBioCardia, Inc.: BioCardia Reports First Quarter 2024 Business Highlights and Financial ResultsMay 15, 2024 | finanznachrichten.deBioCardia Inc (BCDA) Q1 2024 Earnings Call Transcript Highlights: Strategic Progress Amid ...May 15, 2024 | finance.yahoo.comBCDA Stock Earnings: BioCardia Reported Results for Q1 2024May 14, 2024 | investorplace.comBioCardia Reports First Quarter 2024 Business Highlights and Financial ResultsMay 14, 2024 | globenewswire.comMost Shareholders Will Probably Find That The Compensation For BioCardia, Inc.'s (NASDAQ:BCDA) CEO Is ReasonableMay 14, 2024 | finance.yahoo.comBioCardia to Host Q1 2024 Financial Results and Corporate Update Conference Call on May 14, 2024May 9, 2024 | globenewswire.comBioCardia’s CardiAMP Cell Therapy Chronic Myocardial Ischemia Trial Results Show Patient Benefits in Important OutcomesMay 1, 2024 | finance.yahoo.comBioCardia's CardiAMP Cell Therapy Chronic Myocardial Ischemia Trial Results Show Patient Benefits in Important OutcomesMay 1, 2024 | globenewswire.comBioCardia Completes Enrollment of CardiAMP Cell Therapy for the Treatment of Chronic Myocardial Ischemia Trial Open Label Roll-In CohortApril 25, 2024 | globenewswire.comBioCardia, Inc. (NASDAQ:BCDA) Q4 2023 Earnings Call TranscriptApril 1, 2024 | finance.yahoo.com Get BioCardia News Delivered to You Automatically Sign up to receive the latest news and ratings for BCDA and its competitors with MarketBeat's FREE daily newsletter. Email Address BCDA Media Mentions By Week BCDA Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. BCDA News Sentiment▼1.000.60▲Average Medical News Sentiment BCDA News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. BCDA Articles This Week▼01▲BCDA Articles Average Week Get BioCardia News Delivered to You Automatically Sign up to receive the latest news and ratings for BCDA and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies VYNE News BIVI News LTRN News SRZN News DTIL News ATRA News PASG News RLYB News VIRI News RNXT News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:BCDA) was last updated on 1/21/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode in 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredThis coin could surge during Trump’s first week in office.Juan has never had a losing trade on Bitcoin. And he booked gains of 312% on Chainlink … Now, he says one v...Weiss Ratings | SponsoredElon’s New AI Firm REVEALEDNvidia’s AI chip … the H100 … has been the holy grail of artificial intelligence… Until now. Because Elo...Paradigm Press | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BioCardia, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share BioCardia With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
